TRUST CO OF VERMONT - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 107 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUST CO OF VERMONT ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,000
-73.3%
400
-71.4%
0.00%
-100.0%
Q1 2021$15,000
-31.8%
1,4000.0%0.00%
-50.0%
Q4 2020$22,000
+10.0%
1,4000.0%0.00%0.0%
Q3 2020$20,000
-47.4%
1,400
-30.0%
0.00%
-50.0%
Q2 2020$38,0000.0%2,0000.0%0.00%0.0%
Q1 2020$38,000
+22.6%
2,000
+25.0%
0.00%
+100.0%
Q4 2019$31,000
+93.8%
1,6000.0%0.00%
+100.0%
Q3 2019$16,000
+60.0%
1,6000.0%0.00%0.0%
Q2 2019$10,000
+42.9%
1,600
+45.5%
0.00%0.0%
Q1 2019$7,000
+16.7%
1,100
+83.3%
0.00%0.0%
Q4 2018$6,0006000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 999,275$37,403,00055.08%
New Leaf Venture Partners, L.L.C. 126,687$4,742,0002.31%
Cormorant Asset Management, LP 385,000$14,411,0002.22%
SECTORAL ASSET MANAGEMENT INC 529,920$19,835,0000.89%
PFM Health Sciences, LP 850,337$31,828,0000.74%
Partner Investment Management, L.P. 16,399$614,0000.25%
Tekla Capital Management LLC 137,766$5,157,0000.24%
Candriam S.C.A. 298,000$11,154,0000.23%
Eventide Asset Management 30,000$1,123,0000.12%
DRIEHAUS CAPITAL MANAGEMENT LLC 81,047$3,034,0000.12%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders